Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panobinostat Monotherapy in HER2+ Breast Cancer
NCT00777335Phase 2Terminated
- Sponsor
- Translational Research In Oncology
- Start
- Feb 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of panobinostat in breast cancer (2 arms), sponsored by Translational Research In Oncology. Primary endpoint: Overall Response Rate. Started Feb 2009; status: terminated.
02
Drugs
panobinostat
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00777335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00777335.